You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Clodronate reduced the incidence of bony and visceral metastases in patients with breast cancer and tumour cells in the bone marrow

Article info

Article menu
Download PDFPDF
Therapeutics
Clodronate reduced the incidence of bony and visceral metastases in patients with breast cancer and tumour cells in the bone marrow

Citation

Clodronate reduced the incidence of bony and visceral metastases in patients with breast cancer and tumour cells in the bone marrow
BMJ Evidence-Based Medicine 1999;4:43.
Online issue publication 
March 30, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions